REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/06/2026
Back to search
Official data from USPTO
SOLA PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SOLA PHARMACEUTICALS
ST13
US500000090033748Class
5
Filing
90033748
Registration
6407089
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
18
Latest update
07/06/2026
Trademark type
Word
Nice classes
5
Filing date
07/02/2020
Registration date
07/06/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/06/2021
Last transaction
07/06/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
08/01/2015
First use in commerce
12/01/2015
Drawing code
4
Owner type
16
Owner location
Baton Rouge, LA, US
Examiner
CAHILL, CLARE GALLAGHER
Law office
L40
Current location
TMEG LAW OFFICE 104
Holders and representatives
Holders
SOLA Pharmaceuticals, LLC.
Representatives
SOLA PHARMACEUTICALS, LLC. SOLA PHARMACEUTICALS, LLC.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical medicationspharmaceutical preparations for treating pain and skin conditions
Publications
History of USPTO decisions and trademark events.
18 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/06/2021
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
05/27/2021
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
12/15/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/17/2020
PUBO
PUBLISHED FOR OPPOSITION
11/17/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/28/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/13/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
10/13/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/13/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
10/13/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/13/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/13/2020
GNRT
NON-FINAL ACTION E-MAILED
10/13/2020
CNRT
NON-FINAL ACTION WRITTEN
10/13/2020
DOCK
ASSIGNED TO EXAMINER
10/07/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/30/2020
NWAP
NEW APPLICATION ENTERED
07/06/2020
Continuous trademark protection
Get notified about every new filing that threatens SOLA PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.